Europe — EMA
Norepinephrine Kabi (Noradrenaline Tartrate)
GNH USA supplies Norepinephrine Kabi (noradrenaline tartrate), a vasopressor for hypotension, septic shock and cardiac arrest.
Request sourcing
What is Noradrenaline Tartrate?
Noradrenaline tartrate, the active ingredient in Norepinephrine Kabi, is a vasopressor presented as a solution for injection for intravenous use. It treats acute hypotension, septic shock, and cardiac arrest in critical care settings.
GNH USA supplies Norepinephrine Kabi as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.
What is Noradrenaline Tartrate used for?
Norepinephrine Kabi acts on the adrenergic system to restore circulatory stability in severe cardiovascular emergencies.
Hypotension: restores vascular tone and raises blood pressure in patients with acute low blood pressure. Septic shock: supports hemodynamics by increasing systemic vascular resistance in septic patients. Cardiac arrest: provides circulatory support during resuscitation efforts.
What are the side effects of Noradrenaline Tartrate?
Norepinephrine Kabi may be associated with a range of adverse reactions.
Common Side Effects: - Headache - Tremor - Palpitations - Nausea
Serious or Rare Side Effects: - Severe hypertension - Cardiac arrhythmia - Myocardial ischemia - Peripheral ischemia
What precautions apply to Noradrenaline Tartrate?
When using Norepinephrine Kabi, careful monitoring and specific safety measures are required.
Dose titration: adjust infusion rate to achieve target arterial pressure. Cardiovascular monitoring: continuous ECG and invasive blood pressure monitoring are essential. Extravasation risk: avoid infiltration and inspect the IV site frequently. Concomitant MAO inhibitors: may potentiate pressor response, requiring heightened vigilance. Pregnancy: use only if the potential benefit justifies the potential risk (category unknown). Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Noradrenaline Tartrate interact with?
Norepinephrine Kabi can interact with several drug classes, influencing its pressor effect.
Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Beta‑blockers: may blunt beta‑1 mediated cardiac effects. - Tricyclic antidepressants: additive increase in blood pressure.
Moderate Interactions (Monitor Closely): - Vasodilators (e.g., nitroglycerin, nitroprusside): may require higher norepinephrine doses. - Calcium channel blockers: can modify vascular response. - Diuretics: may affect intravascular volume and pressor requirements.



